Language selection

Search

Patent 2336357 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2336357
(54) English Title: BLOOD CHUNKS
(54) French Title: ALIMENTS EN MORCEAUX POUR ANIMAUX A BASE DE SANG
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A23J 3/12 (2006.01)
  • A23J 3/22 (2006.01)
  • A23J 3/28 (2006.01)
(72) Inventors :
  • FISHER, TIM (United Kingdom)
  • SPEIRS, CHARLES (United Kingdom)
(73) Owners :
  • MARS UK LIMITED
(71) Applicants :
  • MARS UK LIMITED (United Kingdom)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1999-07-02
(87) Open to Public Inspection: 2000-01-13
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/GB1999/002106
(87) International Publication Number: WO 2000001247
(85) National Entry: 2000-12-29

(30) Application Priority Data:
Application No. Country/Territory Date
9814395.1 (United Kingdom) 1998-07-02
9814396.9 (United Kingdom) 1998-07-02

Abstracts

English Abstract


The invention provides a method of manufacturing a blood chunk. The method
comprises heating a blood fraction, adding hydrogen peroxide, and compressing
the resulting reaction product to form a chunk having a laminar structure. An
edible chunk comprising a major proportion of blood protein and having a
fibrous, laminar internal structure is also described.


French Abstract

L'invention concerne un procédé de fabrication d'aliments en morceaux pour animaux à base de sang. Ledit procédé consiste à chauffer une partie du sang; à ajouter du peroxyde d'hydrogène; et à comprimer le produit de réaction obtenu pour former des morceaux à structure lamellaire. L'invention concerne également des aliments en morceaux comestibles à structure interne lamellaire fibreuse composés essentiellement de protéines sanguines.

Claims

Note: Claims are shown in the official language in which they were submitted.


- 6 -
CLAIMS
1. A method of manufacturing a blood chunk comprising:
heating a blood fraction (as herein defined); adding
hydrogen peroxide; and compressing the resulting reaction
product to form a chunk having a laminar structure.
2. A method according to claim 1 in which the blood
fraction is a haemoglobin fraction (as herein defined).
3. A method according to claim 1 or 2 in which the
compression is carried out at a temperature greater than
60°C.
9. A method according to any preceding claim in which the
compressed product is dried.
5. A method according to any preceding claim further
comprising steaming the reaction product of the blood
fraction and the hydrogen peroxide.
6. A method according to any preceding claim in which the
hydrogen peroxide is added to the blood fraction at at least
0.5% (by weight).
7. A method according to any preceding claim in which the
blood fraction is heated to between 60°C and 80°C before
addition of the hydrogen peroxide.
8. A method according to any preceding claim in which the
blood fraction comprises at least 10%, preferably at least
15%, protein by weight.
9. An edible chunk comprising a major proportion of blood
protein and having a fibrous, laminar internal structure.

-7-
10. A method substantially as described.
11. A chunk substantially as described.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02336357 2000-12-29
WO 00/01247 PGT/GB99/02106
- 1 -
BLOOD CHUNKS
The present invention relates to the preparation of a novel
edible chunk comprising blood, and to the chunk itself.
Blood and blood fractions are used in the manufacture of pet
foods as a nutrient. In particular, the h~noglobin fraction
of whole blood is employed; by the hemoglobin fraction is
meant the residue from whole blood once the plasma, or most
of the plasma, has been removed. '~'he haemoglobin fraction
consists of red and white blood ells with a residue of
plasma. The hemoglobin fraction typically contains from
about 14% to 40% protein and about 35% to 45% red blood
cells. The remainder is mainly water together with other
blood components.
Conventionally, whole blood is heated by scraped surface
heating or steam infusion to 75°C and treated with hydrogen
peroxide to decolour it. The decoloured blood is dewatered
2o to give a powder. In alternative techniques, whole blood is
coagulated with for example a solution containing calcium
ions and the resulting coagulate cut into chunks. Such
chunks are homogeneous in texture, resembling liver.
It has now been found that if a blood fraction, defined
herein as comprising from about 14% to about 40% protein and
about 35% to 45% red blood cells, is heated and treated with
hydrogen peroxide a solid foam results. The foam reaction
product can be cut into chunks and incorporated into, for
example, pet food. If the foam reaction product is
compressed, a textured solid mass is produced. The
compressed solid mass has a laminar structure similar to
that of cooked meat.
SUBSTITUTE SHEET (RULE 2G)

CA 02336357 2000-12-29
WO 00/01247 PCT/GB99/02106
- 2 -
The blood fraction may be formed in any way. The blood
fraction may be the haemoglobin fraction of blood.
Alternatively, the blood fraction may be formed by removing
water from whole blood to concentrate it so that it
comprises from about 14$ to about 40~ protein and about 35~
to 45$ red blood cells. The blood fraction may be
reconstituted from purified protein and red blood cells.
According to the invention there is provided a method of
1o forming a blood chunk comprising heating a blood fraction
(as defined above), treating the heated blood fraction with
hydrogen peroxide and compressing the resulting reaction
product to form a chunk having a laminar structure.
Preferably the blood fraction is a haemoglobin fraction (as
defined above).
Preferably the hydrogen peroxide is added to the blood
fraction at at least 0.5$ by weight. There does not appear
to be a significant upper limit to the concentration of
hydrogen peroxide in the reaction mixture which is effective
2o to cause the desired reaction to take place; concentrations
of up to 30 (by weight) have been found satisfactory.
Preferably, compression is carried out at a temperature
greater than 60°C.
Preferably the blood fraction is heated to between 60°C and
80°C before addition of the hydrogen peroxide.
Preferably the blood fraction comprises at least about 10~,
more preferably at least about 15$, by weight protein. At
lower protein concentrations, the reaction product does not
absorb all the water present in the reaction mixture. Such
products are useful and their manufacture falls within the
scope of the present invention; however, it will usually be
SUBSTITUTE SHEET (RULE 26)

CA 02336357 2000-12-29
WO 00/01247 PCT/GB99/02106
- 3 -
necessary to remove the proteinaceous material from the
unabsorbed water before it is used.
Additives may be included in the blood fraction to modify
s the nutritional content and flavour of the chunks. It is
preferred that the pH of the blood fraction is no less than
4, and that it is no greater than 9.
Compression of the reaction product of the blood fraction
and hydrogen peroxide can be carried out on the reaction
1o product as it is formed, or the reaction product can be
stored and then subjected to heating, for example by
microwave radiation, prior to compressing. Alternatively,
the reaction product may be steamed to give a product having
a jelly-like texture. The steaming can be carried out with
15 meat juices or other flavoured aqueous media to impart
particular flavours to the product.
The product can be dried, preferably at about 60°C, to
produce hard, crunchy chunks, which are useful as a dry pet
food.
2o The reaction product of the blood fraction and hydrogen
peroxide can be compressed under its own weight.
The reaction product may be compressed as a result of
restriction of any expansion of the reaction product caused
by evolution of gas as the blood fraction and hydrogen
25 peroxide react.
The pressure at which the reaction product of the blood
fraction and hydrogen peroxide is compressed to achieve the
laminar internal structure is not critical; a pressure of up
to about 400 kPa is preferred.
SUBSTITUTE SHEET (RULE 26)

CA 02336357 2000-12-29
WO 00/01247 PCT/GB99/02106
_ g _
Also according to the invention there is provided an edible
chunk comprising a major amount of blood protein and having
a fibrous, laminar internal structure.
The invention will be further described, by way of example,
with reference to the drawings in which;
Figure 1 shows schematically a method according to a first
embodiment of the invention;
Figure 2 shows schematically a method according to a second
1o embodiment of the invention; and
Figure 3 shows schematically a method according to a third
embodiment of the invention.
The methods according to the invention shown in the drawings
include the following common features. The hemoglobin
fraction of blood is pumped from a tank 10 by a peristaltic
pump 12 to a steam infuser 14 where the haemoglobin is heated
to about 75°C. The heated haemoglobin passes from the steam
infuser 14 to a high shear mixer reactor 16, such as a
Dispax reactor. In the Dispax reactor, the hxmoglobin is
2o reacted with hydrogen peroxide pumped from a hydrogen
peroxide tank 18 by a hydrogen peroxide .pump 20. In the
reactor 16, the hemoglobin and the hydrogen peroxide are
mixed efficiently. Preferably, the reactor is a high shear,
low volume mixer to ensure adequate mixing of the two
components.
In the first embodiment of the invention, shown in Figure 1,
the foam reaction product 22 is deposited in a tray 24. The
reaction product 22 can be allowed to be compressed by its
own weight, in which case the solid mass produced is elastic
3o and can be cut up to provide elastic chunks. Alternatively,
pressure can be applied to the reaction product 22 in the
SUBSTITUTE SHEET (RULE 26)

CA 02336357 2000-12-29
WO 00/01247 PCT/GB99/OZ106
- 5 -
tray by application of a pressure plate 26. On release of
the pressure plate a solid product 28 having a fibrous,
laminar internal structure is produced, which can then be
cut into chunks 30 as at 32.
In the second embodiment of the invention, shown in Figure
2, the reaction product 22 from the reactor 16 is passed to
a piston pump 40 in which the reaction product is
compressed. As the reaction product 22 leaves the piston
pump 40, it is diced as at 42 to produce chunks 44 having a
1o fibrous, laminar internal structure.
In the third embodiment of the invention, shown in Figure 3,
the reaction product 22 leaves the reactor 16 through a
disperser 50, from where it passes into a mouth formed by
the widely separated ends of two converging continuous belts
52, 44. The reaction product is compressed between the two
continuous belts, and the resulting solid sheet 56 is cut
into chunks 58 as it leaves the continuous belts 52, 54, as
at 60. Again, the chunks produced have a fibrous, laminar
internal structure.
2o The chunks have a fibrous, laminar internal structure,
similar to that of meat chunks, so that the chunks can be
readily used in canned food stuffs such as pet foods to
provide a protein source which is analogous in appearance
and texture to meat.
SUBSTITUTE SHEET (R ULE 26)

Representative Drawing

Sorry, the representative drawing for patent document number 2336357 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2016-01-01
Inactive: IPC expired 2016-01-01
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Time Limit for Reversal Expired 2005-07-04
Application Not Reinstated by Deadline 2005-07-04
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2004-07-02
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2004-07-02
Letter Sent 2001-08-24
Inactive: Single transfer 2001-07-13
Inactive: Cover page published 2001-04-11
Inactive: First IPC assigned 2001-04-01
Inactive: Courtesy letter - Evidence 2001-03-27
Inactive: Notice - National entry - No RFE 2001-03-21
Application Received - PCT 2001-03-17
Application Published (Open to Public Inspection) 2000-01-13

Abandonment History

Abandonment Date Reason Reinstatement Date
2004-07-02

Maintenance Fee

The last payment was received on 2003-06-03

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Basic national fee - standard 2000-12-29
MF (application, 2nd anniv.) - standard 02 2001-07-03 2001-06-06
Registration of a document 2001-07-13
MF (application, 3rd anniv.) - standard 03 2002-07-02 2002-06-14
MF (application, 4th anniv.) - standard 04 2003-07-02 2003-06-03
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MARS UK LIMITED
Past Owners on Record
CHARLES SPEIRS
TIM FISHER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2001-04-11 1 29
Description 2000-12-29 5 188
Claims 2000-12-29 2 37
Abstract 2000-12-29 1 47
Drawings 2000-12-29 3 36
Reminder of maintenance fee due 2001-03-21 1 112
Notice of National Entry 2001-03-21 1 194
Courtesy - Certificate of registration (related document(s)) 2001-08-24 1 136
Reminder - Request for Examination 2004-03-03 1 116
Courtesy - Abandonment Letter (Request for Examination) 2004-09-13 1 167
Courtesy - Abandonment Letter (Maintenance Fee) 2004-08-30 1 178
Correspondence 2001-03-21 1 23
PCT 2000-12-29 9 321